Medical Inventi S.A.

Manufacture of medical and dental instruments and supplies

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2015-02-19
Share capital
460,407.30 PLN
Average employment (people)
11 (2025)
Activity description

Medical Inventi is a company that develops and commercializes innovative medical products, focusing on improving patient quality of life. It specializes in FlexiOss®, the world's first flexible bone substitute biomaterial, which integrates naturally with patient bone and is used in orthopedics, dentistry, and veterinary medicine to fill bone defects. The company holds exclusive know-how, technologies, and patents related to FlexiOss®.

Registered address
ul. Nałęczowska 14, 20-701 Lublin, Poland
Email
Phone
Social media
Electronic delivery address
AE:PL-71152-57387-DJCDA-28

Financials

Revenue history (in k)

Financial insight

  • The statement flags a going concern risk. Spółka ponosi straty finansowe i wskazuje na ryzyka związane z regulowanym rynkiem wyrobów medycznych oraz koniecznością finansowania działalności z zewnętrznych źródeł.

From the notes

Current income tax (CIT due)-$708
Profit allocationLoss covered
Loans and borrowings$251,130
Capital expenditure$1,779,207
Planned capital expenditure (next year)$367,656
Foreign sales24.53% of revenue ($41,101)

Filing timeliness

2 of 6 financial statements were filed late (the longest delay 110 days for 2025). All were audited by a statutory auditor.

  • 202502/11/2026
  • 202401/07/2025
  • 202303/07/2024
  • 202206/07/2023
  • 202114/10/2022
  • 202028/09/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Division · Other manufacturing219 / 493
Top 44%
Sector · Manufacturing6,486 / 11,963
Top 54%
City · Lublin1,935 / 4,827
Top 40%
Voivodeship · Lubelskie4,540 / 10,168
Top 45%
Country · Poland134,939 / 297,069
Top 45%

Results vs industry

Revenue
This companyUSD 386.21kMedianUSD 287.80kAverageUSD 4.92m
Net profit
This companyUSD -1.21mMedianUSD 10.65kAverageUSD 206.72k
Operating costs
This companyUSD 1.54mMedianUSD 269.05kAverageUSD 4.50m
Assets
This companyUSD 3.05mMedianUSD 221.07kAverageUSD 5.78m

Offer

  • Bone substitute biomaterial
  • Bone implant
  • Bone reconstruction material

Websites

The company has 4 websites. All of them run on WordPress. The sites are available in: Polish, English, German, Arabic and Chinese. Traffic on the sites is measured with Google Analytics.

  • medicalinventi.plMedical Inventi poprawia jakość życia | Medical Inventi S.A.
    WordPress 3.7Google Tag ManagerYoast SEOApache
  • flexioss.plStrona główna – FlexiOss® – biomateriał kościozastępczy nowej generacji
    WordPress 3.7Google AnalyticsGoogle Tag ManagerYoast SEOWPMLApache
  • flexiossdent.plFlexiOss® Dent – biomateriał kościozastępczy nowej generacji dla medycyny regeneracyjnej
    WordPressGoogle Tag ManagerApache

Public procurement

1 tender recorded as contractor, with a total value of $3,453.

SubjectAmount
Supply of dressings, drapes and other equipment, divided into lots
$3,453

Authorized Representatives

Anna Barbara Kasprzak-Czelej age 47 – Vice President of the Management Board
Maciej Jacek Maniecki age 64 – President of the Management Board

Manner of representation

In the case of a one-person management board or a two-person management board, each member of the management board is authorised to submit declarations of will on behalf of the company independently. If the management board consists of at least three members, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to submit declarations of will on behalf of the company.

Supervisory board

Anna Agnieszka Belcarz-Romaniuk age 55 – Supervisory Board Member
Andrzej Sadkowski age 60 – Supervisory Board Member
Antoni Michał Balcerek age 30 – Supervisory Board Member
Maciej Jan Balcerek age 66 – Supervisory Board Member
Grażyna Maria Ginalska age 74 – Supervisory Board Member

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2011-06-28.

  • mBank
    26 1140 1094 0000 2789 8000 1018
  • mBank
    80 1140 1094 0000 2789 8000 1016
  • mBank
    15 1140 1094 0000 2789 8000 1022

Debt

No entries in the National Debtors Register (KRZ).

Secured liabilities

Type
Blank promissory note
Cash deposit

MSiG notices

8 notices recorded in the Court and Commercial Gazette (MSiG).

Publication dateEvent
May 19, 2026Commercial Companies Code notice
Aug 21, 2020Commercial Companies Code notice
Nov 6, 2018Commercial Companies Code notice
Jan 5, 2016Call to creditors
Nov 12, 2015Call to creditors

Public aid

57 public aid cases recorded, with a total value of $2,303,342.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
–
De minimis aid (in accordance with Commission Regulation 2023/2831)
–
De minimis aid (in accordance with Commission Regulation 2023/2831)
–

European Funds

8 projects co-financed from European Funds recorded, with total EU co-financing of $897,499.

ProjectEU co-financing
Development of a technology for delivering drugs into the body, together with the application of FlexiOss Vet series bone substitute products
$58,702
FlexiOss for veterinary medicine – expansion into foreign markets
$39,861
Increasing the competitiveness of Medical Inventi through research and implementation of a biphasic biomaterial for regenerating osteochondral defects.
$219.3K

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Tricomed S.A.
Musi Lublin sp. z o.o.
BHH Mikromed sp. z o.o.
Fabre sp. z o.o.
Orthoget S.A.
Salon Ortopedyczny Or-Tech sp. z o.o.
Mek-Orto sp. z o.o.
Forslab sp. z o.o.
Nano Prime sp. z o.o.
Integris Medical Polska sp. z o.o.

Change history

DateEvent
2026-06-10Share capital increase
2025-02-24Share capital increase
2024-06-28Share capital increase
2023-03-22Share capital increase
2022-01-13Share capital increase

FAQ

Last updated: 2026-11-02